Study guide
27.2 Retinopathy in Systemic Disease
MRCP UK
Track your progress as you read
Finished sections get a check mark.
1 MRCP(UK) Part 1: Exam Overview, Blueprint & Strategy
1.1 Part 1 Format, Delivery and Fees 1.2 The Official Blueprint and Mark Allocation 1.3 Scaled Scoring, Attempt Limits and Best-of-Five Technique
2 Clinical Sciences: Cellular, Genetic & Molecular Medicine
2.1 Organelles, Cytoskeleton & Membrane Transport 2.2 Cell Cycle Control, Apoptosis & Cell Signalling 2.3 Mendelian & Non-Mendelian Inheritance 2.4 Trinucleotide Repeat Disorders & Chromosomal Abnormalities 2.5 Purine, Pyrimidine Metabolism & the Porphyrias 2.6 Glycogen, Lipid Storage & Amino Acid Disorders
3 Clinical Sciences: Anatomy, Physiology & Immunology
3.1 Clinical & Cross-Sectional Anatomy 3.2 Systemic Clinical Physiology & Homeostasis 3.3 Clinical Immunology & Hypersensitivity Reactions
4 Clinical Sciences: Statistics, Epidemiology & Trial Design
4.1 Study Designs & Evidence Hierarchy 4.2 Diagnostic Testing, Screening & Predictive Values 4.3 Statistical Analysis & Risk Quantification
5 Clinical Pharmacology, Therapeutics & Toxicology
5.1 Pharmacokinetics & Pharmacodynamics 5.2 Cytochrome P450 Systems & High-Risk Drug Interactions 5.3 Adverse Drug Reactions & Therapeutic Drug Monitoring 5.4 Paracetamol & Salicylate Poisoning 5.5 Toxidromes, Antidotes, Carbon Monoxide & Toxic Alcohols
6 Cardiology: Coronary Artery Disease & Heart Failure
6.1 Acute Coronary Syndromes & Myocardial Infarction 6.2 Heart Failure & Cardiomyopathies 6.3 Cardiac Assessment & ECG Interpretation
7 Cardiology: Arrhythmias, Valvular & Pericardial Disease
7.1 Atrial Fibrillation, Narrow & Broad Complex Tachycardias 7.2 Bradyarrhythmias, Conduction Block & Antiarrhythmic Drugs 7.3 Valvular Heart Disease & Murmur Interpretation 7.4 Infective Endocarditis 7.5 Pericardial & Acute Aortic Diseases
8 Respiratory Medicine: Airway & Parenchymal Lung Disease
8.1 Asthma: Diagnosis, Chronic Management & Acute Attacks 8.2 COPD: GOLD Staging, Stable Management, Exacerbations & NIV 8.3 Interstitial Lung Disease & Sarcoidosis 8.4 Respiratory Infections & Bronchiectasis
9 Respiratory Medicine: Vascular, Pleural & Sleep Disorders
9.1 Venous Thromboembolism & Pulmonary Embolism 9.2 Pleural Effusion & Pneumothorax 9.3 Respiratory Failure & Sleep-Disordered Breathing
10 Gastroenterology: Luminal Gastrointestinal Disease
10.1 GORD, Barrett's Oesophagus & Oesophageal Motility Disorders 10.2 Peptic Ulcer Disease, Helicobacter pylori & Zollinger-Ellison Syndrome 10.3 Crohn's Disease, Ulcerative Colitis & Extraintestinal Manifestations 10.4 IBD Medical Therapy, Coeliac Disease & Malabsorption 10.5 Acute Upper Gastrointestinal Bleeding: Risk Scores, Ulcer & Variceal Haemorrhage 10.6 Lower Gastrointestinal Disorders & Colonic Neoplasia
11 Gastroenterology: Liver, Biliary & Pancreatic Disease
11.1 Viral Hepatitis A to E 11.2 Autoimmune Hepatitis & Metabolic Liver Disease 11.3 Cirrhosis & Complications of Portal Hypertension 11.4 Cholestatic Liver Disease: PBC and PSC 11.5 Gallstone Disease, Biliary Sepsis & Pancreatitis
12 Endocrinology & Diabetes: Diabetes & Thyroid
12.1 Diabetes: Diagnostic Thresholds, Classification & Pathophysiology 12.2 NICE-Directed Type 2 Therapy & Microvascular Complications 12.3 Acute Diabetic Emergencies (DKA & HHS) 12.4 Thyrotoxicosis, Thyroiditis & Management of Hyperthyroidism 12.5 Hypothyroidism, Subclinical Disease & Thyroid Nodules
13 Endocrinology & Diabetes: Adrenal, Pituitary & Calcium
13.1 Hypopituitarism, Pituitary Apoplexy & Hyperprolactinaemia 13.2 Acromegaly, Diabetes Insipidus & SIADH 13.3 Cushing's Syndrome: Aetiology, Screening & Localisation 13.4 Adrenal Insufficiency & Endocrine Hypertension 13.5 Calcium Regulation & Hypercalcaemia 13.6 Hypocalcaemia & Metabolic Bone Disease
14 Renal Medicine: AKI, Glomerular & Tubulointerstitial Disease
14.1 Acute Kidney Injury & Chronic Kidney Disease 14.2 Nephrotic and Nephritic Syndromes & Primary Glomerular Disease 14.3 Rapidly Progressive Glomerulonephritis 14.4 Tubulointerstitial & Inherited Renal Diseases
15 Renal Medicine: Fluid, Electrolytes & Acid-Base Balance
15.1 Sodium & Water Disorders 15.2 Potassium, Magnesium & Phosphate Disorders 15.3 Acid-Base Disorders & Blood Gas Analysis
16 Neurology: Cerebrovascular, Headache & Demyelinating Disease
16.1 Stroke Classification, Brainstem Syndromes & Hyperacute Reperfusion 16.2 Secondary Prevention, TIA, Carotid Surgery & Intracranial Haemorrhage 16.3 Headache Disorders & Cranial Neuralgias 16.4 Multiple Sclerosis & Central Demyelinating Diseases
17 Neurology: Epilepsy, Movement Disorders & Neuromuscular Disease
17.1 Epilepsy & Acute Seizures 17.2 Movement Disorders & Cognitive Impairment 17.3 Neuromuscular Junction & Peripheral Nerve Disorders
18 Rheumatology: Inflammatory Arthritis & Connective Tissue Disease
18.1 Rheumatoid Arthritis: Pathophysiology, Clinical Features & Diagnosis 18.2 DMARDs, Biologics & Their Toxicities 18.3 Seronegative Spondyloarthropathies 18.4 Systemic Lupus Erythematosus & Drug-Induced Lupus 18.5 Systemic Sclerosis & Scleroderma Renal Crisis 18.6 Sjogren's Syndrome & Inflammatory Myopathies
19 Rheumatology: Systemic Vasculitis & Crystal Arthropathy
19.1 Vasculitis Classification, Large and Medium Vessel Disease 19.2 ANCA-Associated and Immune Complex Small Vessel Vasculitis 19.3 Gout & Calcium Pyrophosphate Deposition Disease
20 Infectious Diseases & Tropical Medicine
20.1 Sepsis-3 Definitions & the Sepsis Six 20.2 Bacterial Meningitis, CSF Interpretation & Toxic Shock Syndrome 20.3 Tuberculosis: Pathogenesis & Clinical Manifestations 20.4 Tuberculosis: Diagnosis & Anti-Tuberculous Therapy 20.5 HIV Infection & Opportunistic Diseases 20.6 Malaria: Species, Life Cycle & Severe Disease 20.7 Enteric Fever, Arboviral Infection & Tissue Parasites
21 Haematology: Anaemias & Red Cell Disorders
21.1 MCV-Based Diagnostic Approach to Anaemia 21.2 Haemolytic and Autoimmune Haemolytic Anaemias 21.3 Membranopathies, Enzymopathies, PNH & Sickle Cell Disease
22 Haematology: Malignancy, Coagulation & Transfusion Medicine
22.1 Acute Leukaemias 22.2 Chronic Leukaemias & Myeloproliferative Neoplasms 22.3 Lymphomas & Plasma Cell Dyscrasias 22.4 Coagulation Cascade & Inherited Bleeding Disorders 22.5 Thrombocytopenia & Thrombotic Microangiopathies 22.6 Transfusion Products & Acute Transfusion Reactions
23 Psychiatry in General Medicine
23.1 Mood & Psychotic Disorders in Medical Patients 23.2 Psychiatric Emergencies & Substance Misuse 23.3 Mental Capacity & UK Mental Health Law
24 Geriatric Medicine
24.1 Comprehensive Geriatric Assessment, Frailty, Delirium & Falls 24.2 Polypharmacy, Deprescribing & Pressure Ulcers
25 Dermatology
25.1 Inflammatory Skin Disease, Immunobullous Disorders & Severe Drug Eruptions 25.2 Cutaneous Malignancy
26 Oncology & Palliative Medicine
26.1 Neutropenic Sepsis, Spinal Cord Compression & SVC Obstruction 26.2 Hypercalcaemia of Malignancy & Tumour Lysis Syndrome 26.3 Palliative Care & End-of-Life Symptom Control
27 Medical Ophthalmology
27.1 The Acute Red Eye & Sudden Painless Visual Loss 27.2 Retinopathy in Systemic Disease
27.2 Retinopathy in Systemic Disease
Key Takeaways Explain This Topic AI
Proliferative diabetic retinopathy is defined by new vessel formation and is treated with panretinal photocoagulation or anti-VEGF therapy.
Grade 4 hypertensive retinopathy adds papilloedema to haemorrhages and exudates and defines accelerated (malignant) hypertension.
Retinitis pigmentosa causes night blindness and tunnel vision with bone-spicule pigmentation, and is associated with Refsum disease, Usher syndrome and abetalipoproteinaemia.
Last updated: September 2026
- 3. Retinopathy in Systemic Disease
- Diabetic Retinopathy
Diabetic retinopathy is a chronic microangiopathy driven by chronic hyperglycaemia, capillary pericyte loss, basement membrane thickening, microvascular occlusion, and VEGF-driven neoangiogenesis.
- Classification (NHS DESP) Defining Fundoscopic Features Clinical Significance & Action
- R0: None Normal fundus; no microvascular lesions Annual digital photographic screening
R1: Background (Mild NPDR) • Microaneurysms (small, circular red dots); • Retinal dot/blot haemorrhages ; • Hard exudates (discrete lipid deposits) Low risk of progression; annual screening; optimize glycemic (HbA1c) and BP control
R2: Pre-Proliferative (Moderate–Severe NPDR) Signs of progressive retinal ischaemia (The 4-2-1 Rule ):; • Multiple blot haemorrhages in all 4 quadrants ; • Venous beading in ≥ 2 quadrants ; • IRMA (Intraretinal Microvascular Abnormalities) in ≥ 1 quadrant ; • Multiple cotton wool spots (nerve fibre layer infarcts) High risk of rapid progression to proliferative disease; routine ophthalmology clinic referral
R3: Proliferative Diabetic Retinopathy (PDR) • Neovascularization at the Disc (NVD) ; • Neovascularization Elsewhere (NVE) ; • Preretinal or vitreous haemorrhage ; • Tractional retinal detachment High risk of catastrophic irreversible blindness; urgent ophthalmology referral for Panretinal Photocoagulation (PRP) laser or intravitreal anti-VEGF
M1: Diabetic Maculopathy • Hard exudates, blot haemorrhages, or retinal thickening/oedema within 1 disc diameter of the fovea ; • Decreased visual acuity (≤ 6/12) in presence of macula lesions Leading cause of visual loss in Type 2 diabetes; treated with intravitreal anti-VEGF or focal macular laser
Hypertensive Retinopathy: Keith-Wagener-Barker Classification
Arterial hypertension damages retinal arterioles through vasoconstriction, intimal hyperplasia, hyalinization, and endothelial necrosis:
Grade 1: Generalized retinal arteriolar narrowing, tortuosity, and increased light reflex (producing the classic "silver wiring" and "copper wiring" appearance).
Grade 2: Grade 1 plus Arteriovenous (AV) nipping / nicking (Salus' sign: deflection, tapering, or banking of venules as they cross rigid, sclerotic arterioles).
Grade 3: Grade 2 plus signs of acute vascular decompensation: "flame-shaped" retinal haemorrhages (superficial nerve fibre layer), cotton wool spots (axoplasmic flow stasis in microinfarcted nerve fibres), and hard exudates radiating circumferentially around the fovea in a "macular star" pattern.
Grade 4 (Malignant / Accelerated Hypertension): Grade 3 plus bilateral optic disc oedema / papilloedema . Represents a medical hypertensive emergency (diastolic blood pressure typically > 120–130 mmHg). Mandates immediate hospital admission and controlled blood pressure reduction with intravenous antihypertensives (e.g. labetalol, nicardipine, or sodium nitroprusside), cautiously lowering mean arterial pressure by no more than 20% to 25% over the first 2 to 4 hours to prevent cerebral, myocardial, or retinal hypoperfusion.
Papilloedema vs. Optic Neuritis
Papilloedema: Defined specifically as bilateral optic disc swelling secondary to raised intracranial pressure (ICP) .
Clinical Triad of Raised ICP: Morning headache (worsened by coughing, bending, or Valsalva), nausea/vomiting, and transient visual obscurations (momentary graying or blacking out of vision lasting seconds, typically triggered by standing up or postural shifts).
Examination: Loss of spontaneous retinal venous pulsations (SVPs), blurring of disc margins (initially nasal), hyperaemic elevated disc, splinter haemorrhages at the disc margin, and an enlarged physiological blind spot on visual field testing. Crucial Exam Pearl: Central visual acuity and pupillary light reflexes are characteristically preserved in early and acute papilloedema (in stark contrast to optic neuritis or ischemic optic neuropathy).
Mandatory Investigation: Urgent neuroimaging ( MRI brain with MR venography ) must be performed to exclude an intracranial space-occupying lesion or cerebral venous sinus thrombosis before considering a lumbar puncture (to prevent fatal tentorial or cerebellar tonsillar herniation / coning).
Optic Neuritis: Idiopathic inflammatory demyelination of the optic nerve (strongly associated with multiple sclerosis). Typically unilateral, presenting in young adults with subacute painful visual loss (worse with extraocular eye movements), marked impairment of colour vision ( dyschromatopsia , red desaturation), and a profound Relative Afferent Pupillary Defect (RAPD) . Fundoscopy is completely normal in two-thirds of cases ( retrobulbar neuritis ).
Retinal Signs of Systemic Infection and Inflammation
The fundus is the only place where small vessels and neural tissue can be inspected directly, and MRCP uses described fundoscopic findings as a shortcut to a systemic diagnosis.
- Finding described in the stem Systemic diagnosis to consider
- Roth spots (white-centred retinal haemorrhages) Infective endocarditis, leukaemia, severe anaemia, vasculitis
- Cotton wool spots in a patient with HIV HIV retinopathy (non-infective, CD4-dependent)
"Pizza pie" or "cheese and ketchup" retinitis with haemorrhage Cytomegalovirus retinitis, CD4 below 50 cells/mm3
Choroidal tubercles Miliary tuberculosis
Candida chorioretinitis with vitreous "fluffy balls" Candidaemia, intravenous drug use, central venous catheter
- Posterior uveitis with candle-wax drippings and periphlebitis Sarcoidosis
- Retinal vasculitis with occlusion in a young adult Behcet disease, systemic lupus erythematosus
Bilateral optic disc swelling with normal acuity and enlarged blind spot Raised intracranial pressure or idiopathic intracranial hypertension
Cytomegalovirus retinitis is a sight-threatening AIDS-defining illness requiring urgent ganciclovir or valganciclovir alongside antiretroviral therapy, and immune recovery uveitis can follow the start of ART.
Drug-Induced Retinal and Optic Toxicity
Drug Ocular toxicity Monitoring
Hydroxychloroquine Bull's-eye maculopathy Baseline and annual screening after five years, earlier with renal impairment or tamoxifen
Ethambutol Dose-related optic neuritis with red-green colour loss Baseline visual acuity and colour vision; warn the patient
- Amiodarone Corneal verticillata (usually asymptomatic); rarely optic neuropathy Symptom-driven
- Vigabatrin Irreversible concentric visual field constriction Regular perimetry
- Isotretinoin Night blindness, dry eye Symptom-driven
- Sildenafil Transient blue-tinged vision None
- Corticosteroids Posterior subcapsular cataract, raised intraocular pressure Pressure checks in prolonged use
- Inherited and Metabolic Retinal Disease
Retinitis pigmentosa should trigger a search for a syndromic cause: Refsum disease (phytanic acid accumulation, deafness, ataxia, ichthyosis, treated by dietary phytanic acid restriction), Usher syndrome (sensorineural deafness), Kearns-Sayre syndrome (mitochondrial, with external ophthalmoplegia and heart block) and abetalipoproteinaemia (acanthocytes, fat malabsorption, vitamin E deficiency). A cherry-red spot without arterial occlusion suggests a lysosomal storage disorder such as Tay-Sachs or Niemann-Pick disease, whereas with a pale retina and sudden painless visual loss it indicates central retinal artery occlusion. Angioid streaks point to pseudoxanthoma elasticum, Paget disease of bone or sickle cell disease.